Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *
- 1 November 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 10 (6) , 460-466
- https://doi.org/10.1046/j.1365-2893.2003.00466.x
Abstract
SCOPUS: ar.jFLWINinfo:eu-repo/semantics/publisheKeywords
This publication has 20 references indexed in Scilit:
- Combination of interferon induction therapy and ribavirin in chronic hepatitis CHepatology, 2001
- A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis C: pretreatment stratification by viral burden and genotypeAmerican Journal of Gastroenterology, 2000
- Einfluss von Ribavirin auf die Dynamik der Hepatitis-C-Virämie bei Interferon-α-behandelten Patienten mit Response oder NonresponseZeitschrift für Gastroenterologie, 2000
- A short induction regimen of interferon‐α is not effective for treatment of relapse in chronic hepatitis C: a randomized trialJournal of Viral Hepatitis, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnoverHepatology, 1998
- Quantification of the initial decline of serum hepatitis c virus RNA and response to interferon alfaHepatology, 1998
- Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivoHepatology, 1996